Exciting news from Synapse, an innovation program run by BI X, designed to foster impactful partnerships between startups, scaleups, established companies, and Boehringer Ingelheim. At Vertical, we are proud to support this initiative by helping Boehringer Ingelheim identify a partner to increase diversity in clinical trials, validate the approach and ensure a smooth piloting experience. We are committed to supporting the success of this pilot with Inato, who are revolutionizing clinical trial recruitment with their focus on diversity and accessibility. Our goal is to facilitate this collaboration, ensuring it meets key performance indicators and exploring the potential for scaling — if all objectives are met. ➡ Learn more about Synapse here: https://lnkd.in/eSWxsA8B
With our innovation program Synapse, run by our digital lab BI X, we foster partnerships between startups, scaleups, established companies, and our business. We've selected Inato as our innovation partner for this year's Synapse pilot project. Inato redefines clinical trial recruitment through their innovative platform that focusses on diversity and accessibility. Learn more about Synapse here: https://lnkd.in/eSWxsA8B